Insulet Corporation [PODD] stock is trading at $258.87, up 0.03%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PODD shares have gain 3.02% over the last week, with a monthly amount glided 5.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on April 29, 2025, when Wolfe Research downgraded its rating to a Peer Perform. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on March 06, 2025, and set its price target to $340. On November 06, 2024, Bernstein initiated with a Outperform rating and assigned a price target of $300 on the stock. Redburn Atlantic started tracking the stock assigning a Buy rating and suggested a price target of $235 on May 30, 2024. Wolfe Research upgraded its rating to a Outperform but $200 remained the price target by the analyst firm on May 07, 2024. Robert W. Baird upgraded its rating to Outperform for this stock on December 21, 2023, and upped its price target to $238. In a note dated December 04, 2023, Morgan Stanley upgraded an Overweight rating on this stock and boosted its target price from $185 to $234.
Insulet Corporation [PODD] stock has fluctuated between $160.19 and $289.46 over the past year. Currently, Wall Street analysts expect the stock to reach $296 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $258.87 at the most recent close of the market. An investor can expect a potential return of 14.34% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 2.07B for the trailing twelve months, which represents a growth of 17.20%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.41 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 256.39 points at the first support level, and at 253.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 260.97, and for the 2nd resistance point, it is at 263.06.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 3.54. As well, the Quick Ratio is 2.73, while the Cash Ratio is 1.8. Considering the valuation of this stock, the price to sales ratio is 8.79, the price to book ratio is 15.00 and price to earnings (TTM) ratio is 44.72.
Transactions by insiders
Recent insider trading involved Frederick Wayne A.I., Director, that happened on Mar 25 ’25 when 1825.0 shares were sold. Director, Frederick Wayne A.I. completed a deal on Mar 25 ’25 to buy 1825.0 shares. Meanwhile, EVP, CPXPO Benjamin Eric sold 12394.0 shares on Jan 21 ’25.
